Home » Topics » Regulatory

Regulatory
RSS

FDA approves SuperGen's NDA to market Mitozytrex

Nov. 20, 2002

First approval for new antipsychotic drug granted by FDA

Nov. 19, 2002

Label change for Biogen's Avonex approved

Nov. 18, 2002

First approval obtained for Cialis

Nov. 15, 2002

Health Canada approves irbesartan for diabetic renal disease

Nov. 13, 2002

Pfizer announces approval of Lipitor for use in children

Nov. 13, 2002

Crestor receives first approval in Europe

Nov. 11, 2002

Myfortic receives first major approval in Switzerland

Nov. 8, 2002

FDA approves new indication for SecreFlo

Nov. 7, 2002

FDA committee recommends approval of Clozaril to treat suicidal behavior

Nov. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.